A detailed history of Provence Wealth Management Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Provence Wealth Management Group holds 3,907 shares of ABBV stock, worth $758,739. This represents 0.33% of its overall portfolio holdings.

Number of Shares
3,907
Previous 3,576 9.26%
Holding current value
$758,739
Previous $533,000 13.51%
% of portfolio
0.33%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $45,545 - $51,295
331 Added 9.26%
3,907 $605,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $107,539 - $124,493
805 Added 29.05%
3,576 $533,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $152,253 - $189,470
-1,149 Reduced 29.31%
2,771 $373,000
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $248,295 - $285,949
1,717 Added 77.94%
3,920 $624,000
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $304,696 - $365,411
2,203 New
2,203 $356,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $343B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Provence Wealth Management Group Portfolio

Follow Provence Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provence Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Provence Wealth Management Group with notifications on news.